Volume 17 - Issue 6 - June, 2005
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Jamey Jacobs; Tim A. Fischell, MD, FACC, FSCAI; Jorge A. Belardi, MD, PhD; Christopher U. Cates, MD; Alfredo E. Rodriguez, MD, PhD; Gregory Braden, MD; Mike Cowley, MD; David Sperling, MD; Robert Fischell, MD
Mike Cowley: Let’s begin with discussing case selection. Which patients should receive drug-eluting stents (DES)? Should they only receive one stent? Should we reserve DES for a select patient population? What should the approach be for...
Mike Cowley: Let’s begin with discussing case selection. Which patients should receive drug-eluting stents (DES)? Should they only receive one stent? Should we reserve DES for a select patient population? What should the approach be for...
Mike Cowley: Let’s begin with...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Tim A. Fischell, MD, FACC, FSCAI; Scott D. Haller, MS; Kamal Ashraf, MD
No-reflow, or slow-reflow, is a common complication during percutaneous coronary intervention in saphenous vein graft (SVG) angioplasty or stenting. No-reflow after SVG intervention is often associated with serious adverse clinical...
No-reflow, or slow-reflow, is a common complication during percutaneous coronary intervention in saphenous vein graft (SVG) angioplasty or stenting. No-reflow after SVG intervention is often associated with serious adverse clinical...
No-reflow, or slow-reflow, is a...
08/01/2008
Journal of Invasive Cardiology
Electrophysiology Corner
08/01/2008
Christopher C. Lang, MBChB; Neil R. Grubb, MD
Temporary pacemakers are associated with high complication rates and if pacing is required for more than 24 hours, the need for repeat intervention to reposition the lead, or re-site the venous access is relatively commonplace.1–4 We describe...
Temporary pacemakers are associated with high complication rates and if pacing is required for more than 24 hours, the need for repeat intervention to reposition the lead, or re-site the venous access is relatively commonplace.1–4 We describe...
Temporary pacemakers are...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Saleem Sharieff, MD, MBBS, FCPS; Tahir Saghir, MBBS, FCPS; Khan Shah-e-Zaman, MBBS, FRCP, MRCP
Percutaneous balloon mitral valvuloplasty (BMV) has been established as an effective alternative to surgery for the treatment of mitral stenosis (MS) in selected patients since its introduction by Inoue et al. in 1984.1 It affords an...
Percutaneous balloon mitral valvuloplasty (BMV) has been established as an effective alternative to surgery for the treatment of mitral stenosis (MS) in selected patients since its introduction by Inoue et al. in 1984.1 It affords an...
Percutaneous balloon mitral...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
08/01/2008
Thomas Apostolou, MD; Eftihia S. Hamodraka, MD; Konstantinos Paravolidakis, MD
The patient was a 44-year-old woman who was admitted to the hospital due to chest pain at rest. Two days later, the patient underwent a coronary angiogram. The angiogram revealed a left anterior descending artery (LAD) following a normal...
The patient was a 44-year-old woman who was admitted to the hospital due to chest pain at rest. Two days later, the patient underwent a coronary angiogram. The angiogram revealed a left anterior descending artery (LAD) following a normal...
The patient was a 44-year-old...
08/01/2008
Journal of Invasive Cardiology
Editorial Message
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers,
It is my hope that the articles in this issue provide cardiovascular healthcare professionals with important information that assists them in the effective management of cardiac patients. Along with these articles, please...
Dear Readers,
It is my hope that the articles in this issue provide cardiovascular healthcare professionals with important information that assists them in the effective management of cardiac patients. Along with these articles, please...
Dear Readers,
It is my hope...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Pierre Leimgruber, MD; Jeffrey Werner, MD; Philip Reid; Kenneth M. Kent, MD, PhD; Richard R. Heuser, MD, FACC, FACP, FESC, FSCAI; Jorge A. Belardi, MD, PhD; Howard A. Cohen, MD
Tim Fischell: Many centers have spent a lot of money on the 25 or so different distal protection devices available today. We are currently preparing a manuscript on a slightly different, simpler, and considerably less expensive approach to...
Tim Fischell: Many centers have spent a lot of money on the 25 or so different distal protection devices available today. We are currently preparing a manuscript on a slightly different, simpler, and considerably less expensive approach to...
Tim Fischell: Many centers have...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Ebru Yalçin, MD; Ugur Ozçelik, MD; Alpay Celiker, MD
Plastic bronchitis is characterized by marked obstruction of the large airways by bronchial casts.1,2 Bronchial casts take the shape of the bronchi of a lobe or a lung.3 These casts may result in mild symptoms or life-threatening disease, and...
Plastic bronchitis is characterized by marked obstruction of the large airways by bronchial casts.1,2 Bronchial casts take the shape of the bronchi of a lobe or a lung.3 These casts may result in mild symptoms or life-threatening disease, and...
Plastic bronchitis is...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Abdul Rashid, MD; Jeremy Ringewald, MD; Jorge Saucedo, MD
Coronary artery revascularization in the pediatric population is rare. Revascularization of the coronary arteries has been carried out with percutaneous transluminal coronary angioplasty (PTCA), stent delivery, and coronary artery bypass...
Coronary artery revascularization in the pediatric population is rare. Revascularization of the coronary arteries has been carried out with percutaneous transluminal coronary angioplasty (PTCA), stent delivery, and coronary artery bypass...
Coronary artery...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Jason Freeman, MD; Joseph A. Diamond, MD; Amgad N. Makaryus, MD; Dennis Katechis, DO; Allison Spatz, MD
Elevated plasma catecholamine levels associated with pheochromocytoma may cause myocardial injury in the absence of clinically significant atherosclerotic coronary artery disease. The cardiovascular manifestations of pheochromocytoma are...
Elevated plasma catecholamine levels associated with pheochromocytoma may cause myocardial injury in the absence of clinically significant atherosclerotic coronary artery disease. The cardiovascular manifestations of pheochromocytoma are...
Elevated plasma catecholamine...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Eduardo Aptecar, MD
The transradial approach for coronary diagnostic and therapeutic interventions is a well-established alternative to the conventional femoral and brachial approaches1–5 and is now widely used in catheterization laboratories worldwide.6...
The transradial approach for coronary diagnostic and therapeutic interventions is a well-established alternative to the conventional femoral and brachial approaches1–5 and is now widely used in catheterization laboratories worldwide.6...
The transradial approach for...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Lee N. Benson, MD, FRCPC; Kyong Jin Lee, MD; Gruschen R. Veldtman, MD, MBChB, FRCP; Yael Garty, MD
Since its initial description in 1982,1 percutaneous balloon dilation (PBD) has supplanted surgical valvotomy as the primary treatment modality for valvar pulmonary stenosis (PS) across all age groups. Short- and intermediate-term results are...
Since its initial description in 1982,1 percutaneous balloon dilation (PBD) has supplanted surgical valvotomy as the primary treatment modality for valvar pulmonary stenosis (PS) across all age groups. Short- and intermediate-term results are...
Since its initial description in...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
P. Syamasundar Rao, MD, FACC
Congenital pulmonary valve stenosis comprises 7.5% to 9% of all congenital heart defects. The pathologic features of the stenotic pulmonary valve vary; the most commonly observed pathology is what is described as a “dome-shaped” pulmonary...
Congenital pulmonary valve stenosis comprises 7.5% to 9% of all congenital heart defects. The pathologic features of the stenotic pulmonary valve vary; the most commonly observed pathology is what is described as a “dome-shaped” pulmonary...
Congenital pulmonary valve...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Plastic Bronchitis Occurring Late after the Fontan Procedure
in a Child: Treatment with Stent Implantation in the Left Pulmonary Artery
Plastic Bronchitis Occurring Late aft...
Plastic bronchitis is characterized by marked obstruction of the large airways by bronchial casts.1,2 Bronchial casts take the shape of the bronchi of a lobe or a lung.3 These casts may result in mild symptoms or life-threatening disease, and...
Plastic bronchitis is characterized by marked obstruction of the large airways by bronchial casts.1,2 Bronchial casts take the shape of the bronchi of a lobe or a lung.3 These casts may result in mild symptoms or life-threatening disease, and...
Plastic bronchitis is...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Robert D. Ecker, MD; Charles A. Guidot, MD; Ricardo A. Hanel, MD; J. Christopher Wehman, MD; Lee R. Guterman, PhD, MD; Eric Sauvageau, MD; L. Nelson Hopkins, MD
Over 12,000 carotid angioplasty and stenting (CAS) procedures have been performed worldwide.1 More than 130,000 carotid endarterectomies (CEA) are performed annually in the United States.2 The FDA has already approved CAS with distal...
Over 12,000 carotid angioplasty and stenting (CAS) procedures have been performed worldwide.1 More than 130,000 carotid endarterectomies (CEA) are performed annually in the United States.2 The FDA has already approved CAS with distal...
Over 12,000 carotid angioplasty...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Ehud Grenadier, MD; Michael Kapeliovich, MD; Monther Boulos, MD; Walter Markiewicz, MD; Haim Hammerman, MD; Shahar Lavi, MD, PhD; Doron Aronson, MD; Luis Gruberg, MD; Rafael Beyar, MD, DSc, MPH
In the last decade, primary percutaneous coronary intervention (PCI) has emerged as a superior strategy compared to thrombolytic therapy for coronary reperfusion in acute myocardial infarction patients.1–4 It is associated with lower...
In the last decade, primary percutaneous coronary intervention (PCI) has emerged as a superior strategy compared to thrombolytic therapy for coronary reperfusion in acute myocardial infarction patients.1–4 It is associated with lower...
In the last decade, primary...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
John J. Young, MD
Approximately 1.1 million myocardial infarctions occur annually in the United States and result in about 500,000 deaths. Acute myocardial infarction (AMI) is the result of plaque rupture and thrombus formation, with subsequent occlusion of a...
Approximately 1.1 million myocardial infarctions occur annually in the United States and result in about 500,000 deaths. Acute myocardial infarction (AMI) is the result of plaque rupture and thrombus formation, with subsequent occlusion of a...
Approximately 1.1 million...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Michael S. Kim, MD, FACC, FSCAI; Ramanjit Bagga, MD; Samin K. Sharma, MD, FACC, FSCAI; Mary Duffy, NP; Ajay Agarwal, MD; Annapoorna S. Kini, MD, MRCP, FACC; Paul J. Lee, MD
Treatment of in-stent restenosis (ISR) remains a major challenge in modern interventional cardiology. Intracoronary stenting (ICS) is a major device in percutaneous coronary interventions (PCI).1 Despite advances in ICS techniques and adjunct...
Treatment of in-stent restenosis (ISR) remains a major challenge in modern interventional cardiology. Intracoronary stenting (ICS) is a major device in percutaneous coronary interventions (PCI).1 Despite advances in ICS techniques and adjunct...
Treatment of in-stent restenosis...
08/01/2008
Journal of Invasive Cardiology
Feature
08/01/2008
Patrick McCollam, PharmD; Lida Etemad, PharmD, MS
Several U.S.-based studies have estimated the overall cost of illness for acute coronary syndrome (ACS).1–5 However, these studies either do not address the costs of care for the growing group of patients who undergo coronary...
Several U.S.-based studies have estimated the overall cost of illness for acute coronary syndrome (ACS).1–5 However, these studies either do not address the costs of care for the growing group of patients who undergo coronary...
Several U.S.-based studies have...
08/01/2008
Journal of Invasive Cardiology
